Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review

Keyphrases

• Patient-centered 100%
• Pre-exposure Prophylaxis (PrEP) 100%
• Individuals at Risk 100%
• Narrative Review 100%
• Safety Profile 28%
• Personalization 28%
• Safety Concerns 14%
• Highly Effective 14%
• Phase II Study 14%
• Comprehensive Evaluation 14%
• Randomized Double-blind 14%
• Pharmacokinetics 14%
• High-risk Women 14%
• U.S. Food 14%
• HIV Infection 14%
• Behavioral Characteristics 14%
• HIV Prevention 14%
• Medical History 14%
• Truvada 14%
• Health Traits 14%
• Transgender 14%
• Renal Safety 14%
• Biological Characteristics 14%
• Population at Risk 14%
• Tenofovir Disoproxil Fumarate 14%
• Evidence-based Algorithm 14%
• HIV Acquisition 14%
• Cisgender 14%
• Emtricitabine 14%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Emtricitabine 33%
• Human Immunodeficiency Virus Infection 16%
• Medical History 16%
• Emtricitabine Plus Tenofovir Disoproxil 16%
• Tenofovir Disoproxil 16%
• Pharmacokinetics 16%

Medicine and Dentistry

• Emtricitabine 28%
• Emtricitabine Plus Tenofovir Alafenamide 14%
• Tenofovir Disoproxil 14%
• Tenofovir Alafenamide 14%
• Emtricitabine Plus Tenofovir Disoproxil 14%